Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion
The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk's Wegovy and Ozempic.
Source link
- Wagner Group fighters serving as instructors in ongoing Belarus military training
- Merih Demiral turns down offer from Turkey
